Phapros Tbk Pt Stock Price To Earning
| PEHA Stock | IDR 304.00 6.00 2.01% |
Phapros Tbk PT fundamentals help investors to digest information that contributes to Phapros Tbk's financial success or failures. It also enables traders to predict the movement of Phapros Stock. The fundamental analysis module provides a way to measure Phapros Tbk's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phapros Tbk stock.
Phapros |
Phapros Tbk PT Company Price To Earning Analysis
Phapros Tbk's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Phapros Tbk Price To Earning | 7.62 X |
Most of Phapros Tbk's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phapros Tbk PT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Phapros Tbk PT has a Price To Earning of 7.62 times. This is 70.51% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The price to earning for all Indonesia stocks is 73.47% higher than that of the company.
Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Phapros Fundamentals
| Return On Equity | 0.0224 | |||
| Return On Asset | 0.0352 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.5 T | |||
| Shares Outstanding | 840 M | |||
| Shares Owned By Insiders | 71.56 % | |||
| Price To Earning | 7.62 X | |||
| Price To Book | 0.82 X | |||
| Price To Sales | 0.51 X | |||
| Revenue | 1.05 T | |||
| Gross Profit | 502.07 B | |||
| EBITDA | 109.5 B | |||
| Net Income | 11.07 B | |||
| Cash And Equivalents | 400 M | |||
| Cash Per Share | 210.68 X | |||
| Total Debt | 263.28 B | |||
| Debt To Equity | 1.33 % | |||
| Current Ratio | 1.25 X | |||
| Book Value Per Share | 869.00 X | |||
| Cash Flow From Operations | 189.92 B | |||
| Earnings Per Share | 20.00 X | |||
| Number Of Employees | 1.55 K | |||
| Beta | 0.28 | |||
| Market Capitalization | 588 B | |||
| Total Asset | 1.84 T | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.01 % | |||
| Net Asset | 1.84 T |
About Phapros Tbk Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phapros Tbk PT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phapros Tbk using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phapros Tbk PT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Phapros Stock
Phapros Tbk financial ratios help investors to determine whether Phapros Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Phapros with respect to the benefits of owning Phapros Tbk security.